Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00765321
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
CH6 | {(4Z)-2-[(1S)-1-amino-3-(methylsulfanyl)propyl]- 4-[(4-hydroxyphenyl)methylidene]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A | 2H5Q | 0.71 |  |
| CH6 | {(4Z)-2-[(1S)-1-amino-3-(methylsulfanyl)propyl]- 4-[(4-hydroxyphenyl)methylidene]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A | 1XQM | 0.71 | |
| CH6 | {(4Z)-2-[(1S)-1-amino-3-(methylsulfanyl)propyl]- 4-[(4-hydroxyphenyl)methylidene]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A,B | 2QLG | 0.71 | |
| CH6 | {(4Z)-2-[(1S)-1-amino-3-(methylsulfanyl)propyl]- 4-[(4-hydroxyphenyl)methylidene]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A | 1XA9 | 0.71 | |
Y13 | (2E)-3-(3,4-DIHYDROXYPHENYL)-N- [2-(4-HYDROXYPHENYL)ETHYL]ACRYLAMIDE | A | 2EW6 | 0.77 | |
PY9 | 4-{[(2R)-2-(2-methylphenyl)pyrrolidin- 1-yl]carbonyl}benzene-1,3-diol | A,B | 3EKR | 0.72 | |
GN8 | (Z)-3-BENZYL-5-(2-HYDROXY-3-NITROBENZYLIDENE)- 2-THIOXOTHIAZOLIDIN-4-ONE | A,B,C,D,E,F | 2P6F | 0.76 | |
CR7 | [(4Z)-2-[(1S)-1,5-DIAMINOPENTYL]- 4-(4-HYDROXYBENZYLIDENE)-5-OXO- 4,5-DIHYDRO-1H-IMIDAZOL-1-YL]ACETIC ACID | A | 2A47 | 0.7 | |
| CR7 | [(4Z)-2-[(1S)-1,5-DIAMINOPENTYL]- 4-(4-HYDROXYBENZYLIDENE)-5-OXO- 4,5-DIHYDRO-1H-IMIDAZOL-1-YL]ACETIC ACID | A | 2A48 | 0.7 | |
| CR7 | [(4Z)-2-[(1S)-1,5-DIAMINOPENTYL]- 4-(4-HYDROXYBENZYLIDENE)-5-OXO- 4,5-DIHYDRO-1H-IMIDAZOL-1-YL]ACETIC ACID | A | 2A46 | 0.7 | |
SAF | 3-[(1S)-1-(DIMETHYLAMINO)ETHYL]PHENOL | A | 1GQR | 0.71 | |
| SAF | 3-[(1S)-1-(DIMETHYLAMINO)ETHYL]PHENOL | A | 1GQS | 0.71 | |
TYP | CYCLO-(L-TYROSINE-L-PROLINE) INHIBITOR | A,B | 1W1Y | 0.73 | |
TI2 | (2-SULFANYL-3-PHENYLPROPANOYL)- PHE-TYR | A | 1QF0 | 0.7 | |
SD2 | N-(SULFANYLACETYL)TYROSYLPROLYLMETHIONINAMIDE | A,B | 1PWQ | 0.76 | |
AXL | 2-{1-[2-AMINO-2-(4-HYDROXY-PHENYL)- ACETYLAMINO]-2-OXO-ETHYL}-5,5-DIMETHYL- THIAZOLIDINE-4-CARBOXYLIC ACID | B | 1LL9 | 0.7 | |
YTT | (3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine- 2,5-dione | A | 3G5H | 0.72 | |
NLT | N-DODECANOYL-L-TYROSINE | A,B,C,D,E,F, G,H | 2G0B | 0.7 | |
NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | B,D | 2A54 | 0.71 | |
| NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A | 3E5V | 0.71 | |
| NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | B,D | 2A56 | 0.71 | |
| NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | B,D | 2A53 | 0.71 | |
| NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | B,D | 2A50 | 0.71 | |
| NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A,B,G,H | 3CFH | 0.71 | |
| NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A,B,C,D | 3E5W | 0.71 | |
| NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A,B,C,D,E,F, G,H | 3BXC | 0.71 | |
| NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A,B,G,H | 3CFF | 0.71 | |
| NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A | 3E5T | 0.71 | |
| NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A,B,C,D,E,F, G,H | 3BXB | 0.71 | |
| NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | B,D | 2A52 | 0.71 | |
| NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A,B | 2QLG | 0.71 | |
| NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A,B | 3BXA | 0.71 | |
| NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A,B,C,D,E,F, G,H | 2V4E | 0.71 | |
| NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A,B | 2QLI | 0.71 | |
| NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A,B | 1UIS | 0.71 | |
| NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A,B,C,D,E,F, G,H | 1ZGQ | 0.71 | |
| NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A,B,G,H | 3CFA | 0.71 | |
| NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A,B | 2QLH | 0.71 | |
| NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A,B | 3BX9 | 0.71 | |
CCY | 2-(1-AMINO-2-MERCAPTO-ETHYL)-5- (4-HYDROXY-BENZYL)-3-(ETHANOYL)- 3,5-DIHYDRO-IMIDAZOL-4-ONE | A | 1EMK | 0.7 | |
CH7 | [(4Z)-4-(4-HYDROXYBENZYLIDENE)- 5-OXO-2-(3,4,5,6-TETRAHYDROPYRIDIN- 2-YL)-4,5-DIHYDRO-1H-IMIDAZOL-1- YL]ACETIC ACID | A,B | 1XAE | 0.71 | |
| CH7 | [(4Z)-4-(4-HYDROXYBENZYLIDENE)- 5-OXO-2-(3,4,5,6-TETRAHYDROPYRIDIN- 2-YL)-4,5-DIHYDRO-1H-IMIDAZOL-1- YL]ACETIC ACID | A,B,C,D | 2OGR | 0.71 | |